OREX

Orexigen Therapeutics, Inc. News Headlines

$5.13
*  
0.16
3.02%
Get OREX Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Arena Pharmaceuticals: Strong Sell On Multiple Red Flags
6/6/2014 1:15:00 PM - Seeking Alpha

Orexigen To Rise On Very Likely FDA Nod June 11th
6/6/2014 11:58:00 AM - Seeking Alpha

The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming
6/2/2014 8:30:00 AM - Seeking Alpha

Belviq Sales Climb - Are Ads Effective?
5/30/2014 4:46:00 PM - Seeking Alpha

Orexigen (OREX) in Focus: Stock Moves 6.1% Higher - Tale of the Tape
5/29/2014 9:46:00 AM - Zacks.com

Aspen Investment Said To Be Offering $640 Million For Vivus
5/28/2014 4:56:00 PM - Seeking Alpha

Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why
5/28/2014 8:30:00 AM - Seeking Alpha

Arena To Present At Jefferies Conference - Is It A Catalyst?
5/27/2014 5:18:00 PM - Seeking Alpha

Orexigen Will Run: Here's Why
5/27/2014 3:47:00 PM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts: Part 1
5/27/2014 9:34:00 AM - Seeking Alpha

Arena's Belviq Sales Flat-To-Slightly Down
5/23/2014 2:37:00 PM - Seeking Alpha

FDA Panel to Review Novo Nordisk's Victoza 3mg - Analyst Blog
5/21/2014 5:35:00 PM - Zacks.com

Trials Are Expected In Japan And China, But Arena's Belviq International Sales Will Have To Wait
5/14/2014 1:45:00 AM - Seeking Alpha

Wider-than-Expected Loss at Orexigen in Q1 - Analyst Blog
5/12/2014 9:50:00 AM - Zacks.com

Vivus Discloses Competitive Threat
5/10/2014 10:51:00 AM - Seeking Alpha

After Hours Most Active for May 8, 2014 : LLY, BAC, QQQ, MSFT, ATML, RVT, MCP, SIRI, MRK, NEE^O, FB, OREX
5/8/2014 4:44:59 PM - NASDAQ.com News

Vivus Impresses Street - Can It Last?
5/6/2014 12:38:00 PM - Seeking Alpha

Will Arena Seize An Opportunity?
5/6/2014 12:35:00 PM - Seeking Alpha

Vivus Earnings On Tap
5/5/2014 1:13:00 PM - Seeking Alpha

Arena - Script Sales Start Recovery As Television Ads Hit Air
4/25/2014 2:53:00 PM - Seeking Alpha

Arena Pharmaceuticals: 4 Different Insiders Have Sold Shares This Month
4/25/2014 1:32:00 PM - Seeking Alpha

Orexigen's Possible One-Two Punch
4/25/2014 12:06:00 PM - Seeking Alpha

What Arena's Belviq Television Ad Campaign Means For The Stock
4/14/2014 9:22:00 AM - Seeking Alpha

Is Orexigen Attractive Near 52-Week Lows?
4/11/2014 4:34:00 PM - Seeking Alpha

Narrower Loss at Orexigen in Q4 - Analyst Blog
3/13/2014 9:30:01 AM - Zacks.com